Akoustis Technologies, Inc. (AKTS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.26
Day's range
$19.51

Aktis Oncology Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BIOIMPACT CAPITAL LLC 05/15/2026 4.84 M $86.51 M   100.00% 8.75%
ECOR1 CAPITAL, LLC 05/15/2026 4.82 M $86.31 M   100.00% 8.73%
BLUE OWL CAPITAL HOLDINGS LP 05/14/2026 3.16 M $56.56 M   100.00% 5.72%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.32 M $41.45 M   100.00% 4.19%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 2.12 M $38.00 M   100.00% 3.84%
BLACKROCK, INC. 05/13/2026 2.11 M $37.79 M   100.00% 3.82%
RTW INVESTMENTS, LP 05/15/2026 1.59 M $28.48 M   100.00% 2.88%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.56 M $27.99 M   100.00% 2.83%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 1.50 M $26.89 M   100.00% 2.72%
JANUS HENDERSON GROUP PLC 05/18/2026 1.45 M $26.02 M   100.00% 2.63%
BAKER BROS. ADVISORS LP 05/15/2026 996.35 K $17.82 M   100.00% 1.80%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 960.85 K $17.19 M   100.00% 1.74%
MERCK & CO., INC. 05/13/2026 952.84 K $17.05 M   100.00% 1.72%
05/15/2026 833.91 K $14.92 M   100.00% 1.51%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 507.00 K $9.07 M   100.00% 0.92%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 491.94 K $8.80 M   100.00% 0.89%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 468.57 K $8.38 M   100.00% 0.85%
STATE STREET CORP 05/15/2026 428.25 K $7.66 M   100.00% 0.77%
AH CAPITAL MANAGEMENT, L.L.C. 05/15/2026 415.00 K $7.42 M   100.00% 0.75%
FMR LLC 05/15/2026 386.38 K $6.91 M   100.00% 0.70%
UBS GROUP AG 05/05/2026 353.26 K $6.32 M   100.00% 0.64%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2026 329.47 K $5.89 M   100.00% 0.60%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 290.00 K $5.19 M   100.00% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 162.02 K $2.90 M   100.00% 0.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 150.00 K $2.68 M   100.00% 0.27%
NORTHERN TRUST CORP 05/14/2026 149.48 K $2.67 M   100.00% 0.27%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 127.40 K $2.28 M   100.00% 0.23%
05/08/2026 120.32 K $2.15 M   100.00% 0.22%
AMERIPRISE FINANCIAL INC 05/15/2026 102.93 K $1.84 M   100.00% 0.19%
TD ASSET MANAGEMENT INC 05/11/2026 100.96 K $1.81 M   100.00% 0.18%
SOROS FUND MANAGEMENT LLC 05/15/2026 100.00 K $1.79 M   100.00% 0.18%
LAURION CAPITAL MANAGEMENT LP 05/14/2026 100.00 K $1.79 M   100.00% 0.18%
WOODLINE PARTNERS LP 05/15/2026 100.00 K $1.79 M   100.00% 0.18%
CITADEL ADVISORS LLC 05/15/2026 75.00 K $1.34 M   100.00% 0.14%
BANK OF AMERICA CORP /DE/ 05/18/2026 69.93 K $1.25 M   100.00% 0.13%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 46.99 K $840.71 K   100.00% 0.09%
BANK OF NEW YORK MELLON CORP 05/05/2026 42.90 K $767.50 K   100.00% 0.08%
MORGAN STANLEY 05/15/2026 30.72 K $549.63 K   100.00% 0.06%
GOLDMAN SACHS GROUP INC 05/15/2026 30.16 K $539.62 K   100.00% 0.05%
READYSTATE ASSET MANAGEMENT LP 05/15/2026 30.00 K $536.70 K   100.00% 0.05%
GHISALLO CAPITAL MANAGEMENT LLC 05/15/2026 25.00 K $447.25 K   100.00% 0.05%
SEVEN GRAND MANAGERS, LLC 05/06/2026 25.00 K $447.25 K   100.00% 0.05%
NUVEEN, LLC 04/30/2026 24.47 K $437.73 K   100.00% 0.04%
RHUMBLINE ADVISERS 05/12/2026 21.03 K $376.27 K   100.00% 0.04%
D. E. SHAW & CO., INC. 05/15/2026 17.06 K $305.24 K   100.00% 0.03%
ZIMMER PARTNERS, LP 05/15/2026 15.00 K $268.35 K   100.00% 0.03%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 05/11/2026 14.19 K $253.77 K   100.00% 0.03%
DEUTSCHE BANK AG\ 05/06/2026 14.08 K $251.89 K   100.00% 0.03%
XTX TOPCO LTD 05/15/2026 13.99 K $250.28 K   100.00% 0.03%
INVESCO LTD. 05/12/2026 12.11 K $216.70 K   100.00% 0.02%

Aktis Oncology Inc institutional Ownership - FAQ's

During the previous two years, 97 institutional investors and hedge funds held shares of Aktis Oncology Inc. The most heavily invested institutionals were:

BioImpact Capital LLC: 4.84 M

EcoR1 Capital, LLC: 4.82 M

Blue Owl Capital Holdings LP: 3.16 M

WELLINGTON MANAGEMENT GROUP LLP: 2.32 M

T. Rowe Price Investment Management, Inc.: 2.12 M

BlackRock, Inc.: 2.11 M

62.80% of Aktis Oncology Inc stock is owned by institutional investors.

Institutional investors have bought a total of 35.87 M shares in the last 24 months. This purchase volume represents approximately $683.68 M in transactions.